Retinal venous occlusion in a child following Corbevax COVID-19 vaccination

• Published in: Indian journal of ophthalmology Vol. 70; no. 10; pp. 3713 - 3715
• Main Authors: Nangia, Purna, Prakash, V, Dutta Majumder, Parthopratim
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer India Pvt. Ltd 01.10.2022; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd; Wolters Kluwer - Medknow; Wolters Kluwer Medknow Publications
• Subjects: Adolescent; Angiography; Anti-Inflammatory Agents - therapeutic use; Case Reports; Child; corbevax vaccine; Coronaviruses; Corticosteroids; COVID-19; COVID-19 - prevention & control; COVID-19 Vaccines - adverse effects; Diagnosis; Fluorescein; Fluorescein Angiography; Humans; Inflammation; Male; Occlusion; Retina; Retinal diseases; retinal vein occlusion; Retinal Vein Occlusion - chemically induced; Retinal Vein Occlusion - diagnosis; Retinal Vein Occlusion - drug therapy; Risk factors; Vaccination; Vascular occlusion; Vision disorders in children; India; COVID-19; vascular occlusion; Corbevax vaccine; retinal vein occlusion
• ISSN: 0301-4738; 1998-3689
• DOI: 10.4103/ijo.IJO_1927_22

A 13-year-old boy developed painless diminution of vision in left eye 15 days after taking first dose of coronavirus disease 2019 (COVID-19) vaccine (Corbevax). Fundus and fluorescein angiography revealed central retinal vein occlusion in the left eye. Blood investigations were noncontributory. He was administered three doses of pulse corticosteroids followed by a tapering dose of oral corticosteroids. Retinal vascular occlusion can occur following COVID-19 vaccination in children, and early and aggressive systemic anti-inflammatory therapy can be helpful.